# Legacy Pharma Invest LP — Form D

Legacy Pharma Invest LP of TORONTO, A6, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2023-10-24. Industry: Pooled Investment Fund.

## Offering

- Filed: 2023-10-24
- Form: D
- Accession: 0001998028-23-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-495554

## Issuer

- Name: Legacy Pharma Invest LP
- CIK: 0001998028
- Entity type: Limited Partnership
- Jurisdiction: ONTARIO, CANADA
- Incorporated: 2023
- Address: 135 YORKVILLE AVENUE, FLOOR 9, TORONTO, A6, M5R 0C7
- Phone: 416-925-6609

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| James Albrecht | Director | TORONTO, A6 |
| Andrew Lapham | Director | TORONTO, A6 |
| James Albrecht | Executive Officer | TORONTO, A6 |
| Andrew Lapham | Executive Officer | TORONTO, A6 |
| NA Legacy Pharma Invest GP Inc. | Promoter | TORONTO, A6 |

## More

- [CIK 1998028 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1998028&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001998028-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.